首页 | 本学科首页   官方微博 | 高级检索  
     


Synthesis of Fatty Acid Amides of Catechol Metabolites that Exhibit Antiobesity Properties
Authors:Bruno Almeida  Dr Jesús Joglar  María Jesús Luque?Rojas  Juan Manuel Decara  Francisco Javier Bermúdez‐Silva  Dr Manuel Macias‐González  Dr Montserrat Fitó  Miguel Romero‐Cuevas  Dr Magí Farré  Dr María Isabel Covas  Dr Fernando Rodríguez?de?Fonseca  Dr Rafael de?la?Torre
Affiliation:1. Human Pharmacology and Clinical Neurosciences Research Group, Neuropsychopharmacology Research Program, IMIM‐Hospital del Mar Research Institute, Dr. Aiguader 88, Barcelona 08003 (Spain), Fax: (+34)?933160467;2. Universitat Pompeu Fabra, CEXS‐UPF, Dr. Aiguader 88, Barcelona 08003 (Spain);3. CIBEROBN, Instituto de Salud Carlos?III, Madrid (Spain);4. Departamento de Química Biológica y Modelización Molecular, Instituto de Química Avanzada de Catalu?a (IQAC‐CSIC), Jordi Girona 18‐26, 08034 Barcelona (Spain);5. Fundación IMABIS, Hospital Carlos Haya de Málaga, Avda. Carlos Haya 82, Pabellón de Gobierno, 29010 Málaga (Spain);6. Hospital Clínico Virgen de?la Victoria, Campus Universitario Teatinos, 29010 Málaga (Spain);7. Oxidative Stress and Nutrition Research Group, Inflammation and Cardiovascular Research Program, IMIM‐Hospital del Mar, Dr. Aiguader 88, Barcelona 08003 (Spain);8. Universitat Autònoma de Barcelona, UDIMAS‐UAB, Dr. Aiguader 88, Barcelona 08003 (Spain)
Abstract:A series of fatty acid amides of 3,4‐methylenedioxymethamphetamine (MDMA) catechol metabolites were synthesized in order to evaluate their biological activities. Upon administration, all synthesized compounds resulted in negative modulation of food intake in rats. The most active compounds have affinity for the CB1 receptor and/or PPAR‐α; part of their biological activity may be caused by these double interactions.
Keywords:CB1  endocannabinoids  obesity  PPAR‐α    receptors
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号